Search results
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market - ET...
The Economic Times· 16 hours agoLondon: Democratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout from its decision to stop selling one of its long-acting insulins in the country, two ...
Expresso Health News Updates of the week
Indian Express· 22 hours agoLet us begin with our top story: Given Delhi’s air pollution, sulfur dioxide, nitrogen dioxide, and particulate matter can deposit on the scalp and hair leading to dandruff. At the same time ...
Ozempic linked with lower dementia risk, nicotine use, British study finds - ET HealthWorld | Pharma
The Economic Times· 1 day agoLondon: Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive...
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says - ET...
The Economic Times· 1 day agoWeight-loss drugs, including Wegovy and Eli Lilly's Zepbound and Mounjaro, belong to a class known as GLP-1 receptor agonists that slow the process of emptying ...
Vivani to start in-human trial for GLP-1 implant for treating obesity
Medical Device Network· 2 days agoGlobalData estimates that GLP-1 receptor agonist sales for T2D and obesity markets will reach more...
Lupin Summary: Latest Updates and Details | India Infoline
India Infoline· 2 days agoLupin Ltd Summary: Check out the latest management information and corporate updates of Lupin at India Infoline
Pfizer along witth Eli Lilly and Novo Nordisk, enroute to develop their second generation weight...
CNBC TV18· 2 days agoPfizer plans to move a reworked, once-a-day version of its weight loss pill, danuglipron, into...
Pfizer moves forward with once-daily weight loss pill
Clinical Trials Arena· 2 days agoNovo Nordisk currently dominates the space with its GLP-1 agonist drug Wegovy (semaglutide) which...
Impact of AI on metabolic disorder clinical trials
Clinical Trials Arena· 2 days agoMore clinical trials in metabolic research should be expected, especially since pharma giants have entered partnerships with AI companies. For example, ...
Pfizer thinks it found its obesity pill
BioPharma Dive· 3 days agoFar behind companies like Novo and Eli Lilly, Pfizer hopes the version of the drug, danuglipron, that it’s chosen to advance can break into the...